ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION Solicitation ID/Procurement Identifier: 75F40123P00366 Ultimate Completion Date: Tue Sep 24 17:00:00 GMT 2024
Food and Drug Administration’s (FDA), Center for Drug Evaluation and Research (CDER), requires a contract to obtain Active Pharmaceutical Ingredients’ (API), their manufacturing facilities and their activities.Please see enclosed RFP for full details.
Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR), intends to purchase and store Active Pharmaceutical Ingredients (API’s). The Government intends to evaluate offers and award a contract without discussions with Offerors providing the requested services.Performance is anticipated to begin August 1, 2020.
W911SR-23-S-APIMREQUEST FOR INFORMATIONdevelopment of advanced manufacturing capability for active pharmaceutical ingredientsObjective:This is a Request for Information (RFI) for planning purposes only. It is not to be construed as a commitment by the Government nor will the Government pay for the information solicited. No solicitation document exists or is guaranteed to be issued as a result of this RFI.
To obtain API manufacturing facility and product data that can assist CDER in programs that rely on manufacturing information for the purposes of compliance, surveillance, enforcement, drug shortages and user fee collections.See enclosed Sources Sought Notice for full detail of requirement.
ACTIVE PHARMACEUTICAL INGREDIENTS (API) MANUFACTURER DATA ACQUISITION Solicitation ID/Procurement Identifier: 75F40122P00346 Ultimate Completion Date: Sun Sep 24 17:00:00 GMT 2023
Sources Sought Only - API Manufacturec Data AcquisitionSee attached document for full description of the requirement
